Healthcare Sales & Marketing Network News: NovoTTF

Searching News Database: NovoTTF

HSMN NewsFeed - 5 Oct 2015
Novocure Announces CE Mark and First Patient Use of Second Generation Optune System
Devices Oncology Regulatory

HSMN NewsFeed - 11 May 2015
FDA Grants Priority Review Status for Novocure’s PMA Supplement Application of Optune in Newly Diagnosed Glioblastoma
Devices Oncology FDA

HSMN NewsFeed - 24 Jan 2014
Novocure Enrolls First Patient in Pilot Clinical Trial of NovoTTF(TM) Therapy Plus Gemcitabine for First-line Treatment of Advanced Pancreatic Adenocarcinoma
Devices Oncology

HSMN NewsFeed - 10 Dec 2013
Centers for Medicare and Medicaid Services (CMS) Has Established Permanent Billing Codes for the NovoTTF-100A System(TM)
Devices Oncology Reimbursement

HSMN NewsFeed - 19 Nov 2013
Novocure Enrolls First Patients in a Randomized Trial of NovoTTF(TM) Therapy for Patients with Brain Metastases from Non-Small Cell Lung Cancer
Devices Oncology

HSMN NewsFeed - 22 Jan 2013
NCCN Guidelines(R) Recommend NovoTTF(TM) Therapy as a Standard Treatment Option for CNS Cancers
Devices Oncology

HSMN NewsFeed - 2 Dec 2011
Novocure(TM) Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields(TM)) Therapy
Devices Oncology

HSMN NewsFeed - 15 Apr 2011
FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
Devices Oncology FDA

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.